Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease h syndrome
Comorbidity C0019618|histiocytosis
Sentences 28
PubMedID- 23252252 The paper describes a case of diffuse large b-cell lymphoma detected in a patient 13 months after sinus histiocytosis with massive lymphadenopathy (shml) or rosai-dorfman disease (rdd) being diagnosed together with active hepatitis b virus infection.
PubMedID- 20418084 Introduction: rosai-dorfman disease (rdd), also known as sinus histiocytosis with massive lymphadenopathy (shml), is a rare monocyte/macrophage proliferative disorder of varied biological behavior.
PubMedID- 24587931 Here we report a case in a 6-year-old boy of differential diagnoses including dermatopathic lymphadenitis (dl), parasitic infection, kimura's disease, hypersensitivity reactions, cat-scratch disease, sinus histiocytosis with massive lymphadenopathy (shml), hyperplasic lymph nodes, and lymphoma.
PubMedID- 21816647 A 24-year-old woman who had sinus histiocytosis with massive lymphadenopathy (shml, rosai-dorfman disease) also had oligoarthritis.
PubMedID- 26288524 Sinus histiocytosis with massive lymphadenopathy (shml) or rosai-dorfman disease is a non-neoplastic condition which typically presents as massive, bilateral cervical lymphadenopathy and can involve multiple extranodal organ systems such as skin, eyes, and upper respiratory tract in about 28% cases.
PubMedID- 21139947 In 1969, rosai and dorfman first established sinus histiocytosis with massive lymphadenopathy (shml or rdd) as a clinicopathological entry.1 it typically presents with slowly progressive painless massive cervical lymphadenopathy in young adults and resolves spontaneously.
PubMedID- 21630484 Rosai-dorfman disease (rdd) or sinus histiocytosis with massive lymphadenopathy (shml) is a rare disorder typically manifesting as enlarged lymph nodes with or without systemic involvement.
PubMedID- 21331166 Sinus histiocytosis with massive lymphadenopathy (shml) involves primarily the cervical nodes, but its histiocytes are morphologically quite different from those of lch.
PubMedID- 21906971 Rosai and dorfman first described sinus histiocytosis with massive lymphadenopathy (shml) in 1969 with an article detailing 4 cases in which they differentiated this disease entity from the grouping of diseases categorized as histiocytosis x, where it was previously classified.
PubMedID- 24960676 Sinus histiocytosis with massive lymphadenopathy (shml) was first described by rosai and dorfman in 1969 as a disease characterized by nodal histiocytic infiltration (2).
PubMedID- 23361292 Sinus histiocytosis with massive lymphadenopathy (shml) or rosai-dorfman disease (rdd) is a rare, but well-documented entity.
PubMedID- 21431448 Sinus histiocytosis with massive lymphadenopathy (shml) is generally characterized by severe illness and massive cervical lymphadenopathy.
PubMedID- 21475597 Sinus histiocytosis with massive lymphadenopathy (shml) or rosai-dorfman disease (rdd) was first described as a distinct clinicopathological entity by rosai and dorfman in 1969.
PubMedID- 21366466 Sinus histiocytosis with massive lymphadenopathy (shml), also known as rosai-dorfman disease, is a rare self-limiting disorder of histiocytes with unknown etiology.
PubMedID- 22973396 Sinus histiocytosis with massive lymphadenopathy (shml), also known as rosai-dorfman disease (rdd), was first described by rosai and dorfman in 1969.1 it is a rare idiopathic proliferative disorder that is commonly characterized by painless, massive cervical lymphadenopathy.
PubMedID- 20806072 Sinus histiocytosis with massive lymphadenopathy (shml) or rosai-dorfman disease (rdd) is an uncommon but well-defined benign self-limited clinicopathological entity.
PubMedID- 20121618 Abstract sinus histiocytosis with massive lymphadenopathy (shml), also called rosai-dorfman disease, is a rare entity.
PubMedID- 24611075 Rosai-dorfman disease (rdd) is also known as sinus histiocytosis with massive lymphadenopathy (shml).
PubMedID- 20140240 Additional, less common, histiocytic disorders included in class ii are sinus histiocytosis with massive lymphadenopathy (shml, rosai-dorfman syndrome), xanthogranuloma, reticulohistiocytoma and a familial form previously designated as faisalabad histiocytosis [4].
PubMedID- 24427591 Sinus histiocytosis with massive lymphadenopathy (shml) is a benign proliferating histiocytic disorder, predominantly of lymphnodes with extranodal involvement also seen.
PubMedID- 23739703 Sinus histiocytosis with massive lymphadenopathy (shml) was recognized by rosai anddorfman in 1969 as a benign and self-limiting disease.
PubMedID- 24864019 Background: rosai-dorfman disease (rdd), otherwise known as sinus histiocytosis with massive lymphadenopathy (shml), usually affects young adults and commonly presents with massive painless cervical lymphadenopathy.
PubMedID- 20620063 Sinus histiocytosis with massive lymphadenopathy (shml), also known as rosai-dorfman disease (rdd), is an idiopathic histiocytic disorder of lymph nodes and extranodal sites.
PubMedID- 24797172 Rosai-dorfman disease (rdd), also known as sinus histiocytosis with massive lymphadenopathy (shml), is an uncommon benign idiopathic lymphoproliferative disorder.
PubMedID- 24332663 Rosai dorfman disease (rd), also known as sinus histiocytosis with massive lymphadenopathy (shml), is a benign histiocytic proliferative condition of unsubstantiated etiology that most often presents as bilateral painless cervical lymphadenopathy.
PubMedID- 22028755 The first report of sinus histiocytosis with massive lymphadenopathy (shml) was described in 1959, by destombes as a lipid storage disorder developing after inflammation.4.
PubMedID- 22389884 Sinus histiocytosis with massive lymphadenopathy (shml), also known as rosai-dorfman disease [1], is a rare pathological condition characterized by fever and lymph node enlargement.
PubMedID- 26452062 Sinus histiocytosis with massive lymphadenopathy (shml), or rosai-dorfman disease (rdd), is a non-neoplastic, lymphoproliferative disorder that usually resolves spontaneously or with minimal conventional chemotherapy.

Page: 1